HealthEquity, Inc. (NASDAQ:HQY) Stake Boosted by AGF Management Ltd.

AGF Management Ltd. grew its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 3.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 135,857 shares of the company’s stock after purchasing an additional 4,819 shares during the quarter. AGF Management Ltd. owned approximately 0.16% of HealthEquity worth $13,035,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in HQY. Assetmark Inc. boosted its position in shares of HealthEquity by 457.5% during the third quarter. Assetmark Inc. now owns 4,544 shares of the company’s stock worth $372,000 after buying an additional 3,729 shares during the period. Covestor Ltd lifted its position in HealthEquity by 27.4% in the third quarter. Covestor Ltd now owns 1,524 shares of the company’s stock worth $125,000 after purchasing an additional 328 shares during the period. Los Angeles Capital Management LLC lifted its position in HealthEquity by 92.3% in the third quarter. Los Angeles Capital Management LLC now owns 55,597 shares of the company’s stock worth $4,551,000 after purchasing an additional 26,690 shares during the period. GSA Capital Partners LLP acquired a new stake in HealthEquity in the third quarter worth approximately $638,000. Finally, Carrera Capital Advisors acquired a new stake in HealthEquity in the third quarter worth approximately $1,299,000. 99.55% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. BTIG Research upped their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Raymond James increased their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, February 25th. Bank of America increased their price objective on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, The Goldman Sachs Group started coverage on shares of HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 target price on the stock. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus price target of $113.54.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

HealthEquity Stock Performance

Shares of HealthEquity stock opened at $95.74 on Wednesday. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The firm has a market cap of $8.30 billion, a P/E ratio of 87.83, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a 50 day simple moving average of $105.75 and a 200 day simple moving average of $94.80.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the firm earned $0.40 earnings per share. Sell-side analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.